-
Protease and Phosphatase Inhibitor Cocktail Guide
2026-09-16
This EDTA-free 100X cocktail helps limit proteolysis and dephosphorylation during extraction of cells, tissues, yeast, bacteria, and plant samples. It is suited to workflows where metal chelation is undesirable, but its dilution, assay compatibility, and performance for specific targets should be validated rather than assumed.
-
ARL4C in RA: Synoviocyte–Macrophage Dynamics
2026-09-15
This study integrates single-cell and bulk transcriptomics with cellular perturbation, macrophage co-culture, and collagen-induced arthritis experiments to position ARL4C as a regulator of aggressive rheumatoid arthritis fibroblast-like synoviocytes. Its findings connect ARL4C-dependent synoviocyte proliferation and invasion with macrophage polarization, while also providing a framework for testing S-phase activity and therapeutic responses in follow-up studies.
-
Safe DNA Gel Stain for CAR-T Cloning Workflows
2026-09-15
Use Safe DNA Gel Stain to verify plasmids, PCR products, and RNA preparations while reducing reliance on ethidium bromide and UV imaging. Its blue-light-compatible workflow is especially useful when construct integrity and cloning efficiency matter in advanced cell-engineering programs.
-
Lysosomal β-Galactosidase Staining Kit for Senescence
2026-09-14
Use the Lysosomal β-Galactosidase Staining Kit to visualize acidic lysosomal β-galactosidase activity in cultured cells and tissue sections, while keeping its signal distinct from a standalone senescence diagnosis. The workflow is especially useful for chemoresistance studies that need a reproducible chromogenic control alongside molecular and functional senescence readouts.
-
One-step TUNEL Cy3 Apoptosis Detection Kit Guide
2026-09-14
Learn how to apply a Cy3-based TUNEL workflow to cultured cells, frozen tissue, and paraffin sections while separating apoptotic DNA fragmentation from broader cell-death signals. The guide connects assay design with a glioblastoma study of mitochondrial stress, providing practical controls, optimization parameters, and troubleshooting strategies.
-
NU7441 (KU-57788): DNA-PK Assay Strategy
2026-09-13
NU7441 (KU-57788) is a selective DNA-PK probe for connecting kinase inhibition with DNA repair, cell-cycle, and apoptosis readouts. This guide develops an evidence-led assay strategy informed by oncology research and a 2018 study of DNA damage responses in latent HIV-1 infection.
-
Lidocaine With Epinephrine Shortage: Evidence and Solutions
2026-09-12
Bodie, Brodell, and Helms analyze the United States shortage of lidocaine with epinephrine, identifying manufacturer withdrawals and an epinephrine supply bottleneck as the principal causes. Their practice-focused recommendations address dose conservation, multidose-vial stewardship, dilution strategies, syringe stability, and clinically important limitations of substituting plain lidocaine.
-
BI 2536: From Mitotic Arrest to Translational Signal
2026-09-11
BI 2536 is more than a potent PLK1 inhibitor: it is a mechanistic probe for separating reversible cell-cycle arrest from irreversible apoptosis. This thought-leadership guide outlines how to translate its selectivity, assay behavior, and tumor xenograft evidence into stronger cancer research decisions.
-
Brefeldin A: Mapping ER Stress by Trafficking
2026-09-11
Brefeldin A is more than a vesicle transport inhibitor: it is a temporal probe for connecting ER-to-Golgi disruption with protein quality control and apoptosis. This article integrates BFA assay design with UBR1/UBR2 biology to improve mechanistic interpretation in cancer and cell biology research.
-
GPER1 as a Chemoprevention Target in Prostate Cancer
2026-09-10
The reference study identifies G-protein coupled estrogen receptor 1 (GPER1) as a potentially protective regulator during the transition from high-grade prostatic intraepithelial neoplasia to prostate cancer. By combining human samples, public datasets, TRAMP mice, pharmacological perturbation, and cell-based assays, it provides preclinical evidence that GPER1 activation may suppress tumor progression and epithelial-to-mesenchymal transition.
-
Tropisetron Hydrochloride: Assay Workflows
2026-09-10
Build reproducible receptor, transporter, and polarized-cell assays with Tropisetron Hydrochloride while separating 5-HT3 signaling from OCT2/MATE1 effects. This workflow translates comparative antiemetic transporter data into practical concentration selection, controls, and troubleshooting decisions.
-
Vitamin K2, NRF2/FSP1, and Osteoblast Ferroptosis
2026-09-09
Zhang et al. report that vitamin K2 partially preserves bone mass in a dexamethasone-induced osteoporosis model by restoring NRF2/FSP1-associated antioxidant defenses, mitochondrial function, and osteoblast differentiation. The study positions osteoblast ferroptosis and lipid peroxidation as mechanistically relevant features of glucocorticoid-induced osteoporosis, while also providing a framework for testing redox-focused interventions.
-
Deferasirox Pharmacokinetics and Clinical Evidence
2026-09-09
Galanello, Campus, and Origa provide a clinically oriented synthesis of deferasirox pharmacokinetics, pharmacodynamics, efficacy, and safety across transfusion-dependent anemias. The review’s main contribution is linking oral chelation exposure and disease-specific iron burden to practical dosing, monitoring, and interpretation of treatment response.
-
Isoproterenol Sulfate Dihydrate: Assay Logic
2026-09-08
Isoproterenol sulfate dihydrate can do more than accelerate beating in human SAN assembloids. This guide explains how to use beta-adrenergic stimulation as a causal assay layer for separating receptor responsiveness, pacemaker maturation, and neuro-cardiac organization.
-
Birinapant and the Next Frontier in Apoptosis
2026-09-08
MDM1–p53 biology offers a compelling framework for studying chemoradiotherapy sensitivity, while Birinapant (TL32711) provides a pharmacological route to probe IAP-controlled apoptosis. This article connects the two areas, defines a practical validation workflow, and distinguishes mechanistic opportunity from translational evidence.